FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093823 [Registered on: 28/08/2025] Trial Registered Prospectively
Last Modified On: 27/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Study on the comparison of two unani formulations in the management of White patches. 
Scientific Title of Study   A Single-Blind Randomized Clinical trial of Unani formulations in the treatment of Bahaq (Pityriasis). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohd Riyaz Alam 
Designation  PG Scholar 
Affiliation  Ajmal Khan Tibbiya College 
Address  Department of Amraz-e-Jild wa Zohrawiya, Faculty of Unani medicine, Aligarh Muslim University

Aligarh
UTTAR PRADESH
202001
India 
Phone  7302507546  
Fax    
Email  riyazlm103@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ZAMIR AHMAD 
Designation  PROFESSOR 
Affiliation  Ajmal Khan Tibbiya College 
Address  Department of Amraz-e-Jild wa Zohrawiya, Faculty of Unani medicine, Aligarh Muslim University

Aligarh
UTTAR PRADESH
202001
India 
Phone  8475007594  
Fax    
Email  drzamiramrohi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohd Riyaz Alam 
Designation  PG Scholar 
Affiliation  Ajmal Khan Tibbiya College 
Address  Department of Amraz-e-Jild wa Zohrawiya, Faculty of Unani medicine, Aligarh Muslim University

Aligarh
UTTAR PRADESH
202001
India 
Phone  7302507546  
Fax    
Email  riyazlm103@gmail.com  
 
Source of Monetary or Material Support  
Department of Amraz-e-Jild wa Zohrawiya, Ajmal Khan Tibbiya College, AMU, Aligarh 
 
Primary Sponsor  
Name  Department of Amraz-e-Jild wa Zohrawiya 
Address  Ajmal Khan Tibbiya College, Facuylty of Unani Medicine, AMU 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Mohd Riyaz Alam  Ajmal Khan Tibbiya College and Hospital  OPD No. 3, Department of Amraz-e-Jild wa Zohrawiya, AKTC Hospital, Faculty of Unani Medicine, AMU
Aligarh
UTTAR PRADESH 
7302507546

riyazlm103@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Department of Amraze Jild wa Zohrawiya  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L819||Disorder of pigmentation, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparator drug - Sheetraj hindi (Plumbago zeylanica) and Roghan Bedanjeer (Castor oil) Ricinus communis  Sheetraj hindi- (Plumbago zeylanica Linn.), a perennial shrub, also known by the name of “Chitrak”, “Cheeta lakdi” belongs to Plumbaginaceae family. Root is used as drug. In Unani dermatology it is used in the treatment of Pityriasis, itching, Allergy. It also acts as Anti-inflammatory, Anti-microbial and Anti-hyperlipidemic. 
Intervention  Test Drug- Turmus (Lupinus albus) and Roghan Bedanjeer (Castor oil) Ricinus communis   Turmus (Lupinus albus), commonly known as white lupin or lupine, is a leguminous plant. Root of Turmus is used in Zimad form. It is used as antimicrobial, Antifungal, Anti-helmintic, etc 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Includes all gender with age 03 years and above (School going children).
2. Diagnosed cases of Bahaq over hands, legs, neck and face.
3. Patients who agreed to sign the consent form.
 
 
ExclusionCriteria 
Details  1.All gender patients below 03 years.
2.Patients with other concomitant skin diseases.
3.Pregnant and lactating women.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptoms- Hypopigmentation, scaling and itching.  3 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in the condition on the basis of photographs  0, 14th and 21st day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective of the study:

To assess the comparative efficacy & safety of the Topical Application of Turmus and Sheetraj hindi ointment in the treatment of Bahaq. 
Close